Literature DB >> 2758395

Cytogenetics of childhood acute nonlymphocytic leukemia.

S C Raimondi1, D K Kalwinsky, Y Hayashi, F G Behm, J Mirro, D L Williams.   

Abstract

Interest in more precise subclassification of the acute leukemias by cytogenetic criteria led us to identify and characterize the full range of chromosomal abnormalities in 121 children with de novo acute nonlymphocytic leukemia (ANLL). Only 21% of the cases had normal karyotypes; 62% had consistent or recurrent alterations, most commonly inv(16) or del(16), t(8;21), t(15;17), t(9;11), t(11;V) or del(11), and -7 or 7q-; and 17% had miscellaneous, apparently random, clonal abnormalities. Statistically significant associations between chromosomal abnormalities and the morphologic/cytochemical subtypes of ANLL, defined by criteria of the French-American-British (FAB) cooperative group were demonstrated for the t(8;21) in M1 and M2 leukemia, t(15;17) in M3, t(9;11) in M5, and translocations involving 11q23 other than t(9;11) [t(11;V)] or del(11q) in M4 and M5. The chromosome 16 inversion was not restricted to the M4 subtype, as is generally reported, and was not uniformly associated with increased and/or abnormal marrow eosinophils. None of these 121 cases were characterized by the Philadelphia chromosome, nor did any have the t(6;9), t(16;16), or inv(3), which have been noted previously in this disease. In addition to confirming several recognized correlations between recurrent structural chromosome abnormalities and FAB subtypes, this study identified novel abnormalities that have not been reported by others. It also disclosed an unusual heterogeneity of chromosome 16 abnormalities with respect to their distribution among FAB subtypes, their association with marrow eosinophilia, and their participation with other chromosomes in translocations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2758395     DOI: 10.1016/0165-4608(89)90141-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

1.  Childhood acute myeloid leukemia with bone marrow eosinophilia caused by t(16;21)(q24;q22).

Authors:  Nozomu Kawashima; Akira Shimada; Takeshi Taketani; Yasuhide Hayashi; Nao Yoshida; Kimikazu Matsumoto; Yoshiyuki Takahashi; Seiji Kojima; Koji Kato
Journal:  Int J Hematol       Date:  2012-03-09       Impact factor: 2.490

2.  Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations.

Authors:  Saman Abbas; Mathijs A Sanders; Annelieke Zeilemaker; Wendy M C Geertsma-Kleinekoort; Jasper E Koenders; Francois G Kavelaars; Zabiollah G Abbas; Souad Mahamoud; Isabel W T Chu; Remco Hoogenboezem; Justine K Peeters; Ellen van Drunen; Janneke van Galen; H Berna Beverloo; Bob Löwenberg; Peter J M Valk
Journal:  Haematologica       Date:  2014-01-17       Impact factor: 9.941

3.  Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.

Authors:  Sanne Noort; Martin Zimmermann; Dirk Reinhardt; Wendy Cuccuini; Martina Pigazzi; Jenny Smith; Rhonda E Ries; Todd A Alonzo; Betsy Hirsch; Daisuke Tomizawa; Franco Locatelli; Tanja A Gruber; Susana Raimondi; Edwin Sonneveld; Daniel K Cheuk; Michael Dworzak; Jan Stary; Jonas Abrahamsson; Nira Arad-Cohen; Malgorzata Czogala; Barbara De Moerloose; Henrik Hasle; Soheil Meshinchi; Marry van den Heuvel-Eibrink; C Michel Zwaan
Journal:  Blood       Date:  2018-08-27       Impact factor: 22.113

Review 4.  Global characteristics of childhood acute promyelocytic leukemia.

Authors:  L Zhang; A Samad; M S Pombo-de-Oliveira; G Scelo; M T Smith; J Feusner; J L Wiemels; C Metayer
Journal:  Blood Rev       Date:  2014-09-30       Impact factor: 8.250

5.  The amino terminus targets the mixed lineage leukemia (MLL) protein to the nucleolus, nuclear matrix and mitotic chromosomal scaffolds.

Authors:  C Caslini; A S Alarcòn; J L Hess; R Tanaka; K G Murti; A Biondi
Journal:  Leukemia       Date:  2000-11       Impact factor: 11.528

6.  Improved outcome of acute myeloid leukaemia in Down's syndrome.

Authors:  J L Craze; G Harrison; K Wheatley; I M Hann; J M Chessells
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

Review 7.  T-cell lymphoblastic leukemia/lymphoma with t(7;14)(p15;q32) [TCRγ-TCL1A translocation]: a case report and a review of the literature.

Authors:  Kei-Ji Sugimoto; Asami Shimada; Mutsumi Wakabayashi; Yasunobu Sekiguchi; Hiroshi Izumi; Yasunori Ota; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

8.  Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.

Authors:  P H Sorensen; C S Chen; F O Smith; D C Arthur; P H Domer; I D Bernstein; S J Korsmeyer; G D Hammond; J H Kersey
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 9.  Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia.

Authors:  R Stasi; C G Taylor; A Venditti; G Del Poeta; G Aronica; C Bastianelli; M D Simone; F Buccisano; M C Cox; A Bruno
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673

10.  Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.

Authors:  Eva A Coenen; C Michel Zwaan; Dirk Reinhardt; Christine J Harrison; Oskar A Haas; Valerie de Haas; Vladimir Mihál; Barbara De Moerloose; Marta Jeison; Jeffrey E Rubnitz; Daisuke Tomizawa; Donna Johnston; Todd A Alonzo; Henrik Hasle; Anne Auvrignon; Michael Dworzak; Andrea Pession; Vincent H J van der Velden; John Swansbury; Kit-fai Wong; Kiminori Terui; Sureyya Savasan; Mark Winstanley; Goda Vaitkeviciene; Martin Zimmermann; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.